We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Bio-Rad’s Web-Based siLentMer siRNA Search Tool Offers Access to Available Validated Gene Targets

Read time: Less than a minute

Bio-Rad Laboratories, Inc. has launched a new siLentMer™ siRNA search tool available online at www.bio-rad.com/rnaisearch.

The siLentMer siRNA search tool offers a way to review Bio-Rad’s library of validated siRNA gene targets by searching for a siRNA (by gene symbol, NCBI accession number or Bio-Rad catalog number) or browsing either the research panels they are categorized into or an alphabetical listing of the target gene symbols.

Potent, well designed siRNAs are crucial to the specific silencing of a target gene. Bio-Rad’s siLentMer siRNA duplexes are based on the novel Dicer-substrate siRNA technology, which contributes to their high potency and ability to use very low siRNA concentrations per experiment.

Additionally, Bio-Rad employs their expertise in Gene Transfer and PCR by validating each siRNA sequence to ensure its effectiveness in knocking down at least 85% of the target mRNA expression level.

The siLentMer siRNA duplexes offered by Bio-Rad are now categorized into nine panels according to areas of research interest. The current research panels include angiogenesis; apoptosis; carcinogenesis; cell cycle/checkpoint; chromatin regulation; inflammation; kinases; metabolism; and toxicology/ADME.

Additional panels such as stem cell research, DNA damage/ repair, cardiovascular disease, and others will be added later in the year, the company says.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.